Send feedback

PRRT2 p.His232Gln

c.696C>G · rs570108715 · VCV2046903

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
AlphaMissense
likely benign
0.1907 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.000428%, nfe)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
episodic kinesigenic dyskinesia

⚠ Built without this gene's context — gene constraint and dosage, protein structure, pathways, panels and related-variant links were not looked up for this page. why

Computational evidence

Protein change
AlphaMissense0.1907likely benign
REVEL0.041moderately benign-leaning
SaProtLLR -6.11tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not looked up on this page · why
Constraint at this position
ConservationphyloP -0.009GERP -2.5, phastCons 0.001
Regional constrainto/e 1.16unconstrained · MANE · 785 bp · p 0.003 · regional, not allelic
Overall
CADD5.215PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.000428% European (non-Finnish) · 5/1,167,294 alleles
Filtering AF 0.000126% ClinGen BA1/BS1 input FAF95, joint · FAF99 9.1e-05%
Overall 0.000378% 6/1,589,268 alleles · very rare exomes 5/1,437,424 · genomes 1/151,844 · joint denominator
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.00163% 61,328
European (non-Finnish)grpmax 0.000428% 233,459

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
PRRT2
Protein
p.His232Gln
Coding
c.696C>G
MANE Select
NM_145239
dbSNP
rs570108715
Type
single nucleotide variant
Location
chr16:29813750 (GRCh38)
Full PRRT2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

episodic kinesigenic dyskinesia — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Paroxysmal kinesigenic dyskinesia (Orphanet):

Inheritance
Autosomal dominant, Not applicable
Onset
Adolescent, Adult, Childhood, Infancy
Prevalence
1-9 / 1 000 000 (Worldwide)

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/prrt2-p-his232gln (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown